Global Ocular Inflammation Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • receipt Report ID : 150590
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 124
  • list Pharmaceuticals and Healthcare

Eye inflammations or uveitis are becoming a common problem for people across global geographies. New drugs are being discovered to treat ocular inflammations, and companies are investing millions for their approval through regulatory pipelines. Patients are exhibiting a particular preference to the type of ocular inflammation treatment being adopted, considering the range of treatment options, their comparative effectiveness, and convenience in terms of mode of administration.

Scope of the Report:

This report studies the Ocular Inflammation Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Ocular Inflammation Treatment market by product type and applications/end industries.

The global market for ocular inflammation treatment is expected to grow sharply in the coming years. Prominent market players are diversifying their product lines to cater treatment of all forms of uveitis occurring worldwide.

The global Ocular Inflammation Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Ocular Inflammation Treatment.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Allergan Plc.

Cipla Ltd.

Pfizer, Inc.

Novartis AG

Valeant Pharmaceuticals International, Inc.

Alimera Sciences, Inc.

Akorn, Inc.

Abbvie, Inc.

Eyegate Pharmaceuticals, Inc.

pSivida Corporation

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Immunosuppressant

Monoclonal Antibodies

Corticosteroids

Cycloplegic Agents

Antibiotics

Analgesics

Antivirals

Antifungal

Market Segment by Applications, can be divided into

Retail Pharmacies

Hospital Pharmacies

Online Pharmacies

Drug Stores

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Ocular Inflammation Treatment Market Overview

1.1 Product Overview and Scope of Ocular Inflammation Treatment

1.2 Classification of Ocular Inflammation Treatment by Types

1.2.1 Global Ocular Inflammation Treatment Revenue Comparison by Types (2017-2023)

1.2.2 Global Ocular Inflammation Treatment Revenue Market Share by Types in 2017

1.2.3 Immunosuppressant

1.2.4 Monoclonal Antibodies

1.2.5 Corticosteroids

1.2.6 Cycloplegic Agents

1.2.7 Antibiotics

1.2.8 Analgesics

1.2.9 Antivirals

1.2.10 Antifungal

1.3 Global Ocular Inflammation Treatment Market by Application

1.3.1 Global Ocular Inflammation Treatment Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Retail Pharmacies

1.3.3 Hospital Pharmacies

1.3.4 Online Pharmacies

1.3.5 Drug Stores

1.4 Global Ocular Inflammation Treatment Market by Regions

1.4.1 Global Ocular Inflammation Treatment Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Ocular Inflammation Treatment Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Ocular Inflammation Treatment Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Ocular Inflammation Treatment Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Ocular Inflammation Treatment Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Ocular Inflammation Treatment Status and Prospect (2013-2023)

1.5 Global Market Size of Ocular Inflammation Treatment (2013-2023)

2 Manufacturers Profiles

2.1 Allergan Plc.

2.1.1 Business Overview

2.1.2 Ocular Inflammation Treatment Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Allergan Plc. Ocular Inflammation Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.2 Cipla Ltd.

2.2.1 Business Overview

2.2.2 Ocular Inflammation Treatment Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Cipla Ltd. Ocular Inflammation Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.3 Pfizer, Inc.

2.3.1 Business Overview

2.3.2 Ocular Inflammation Treatment Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Pfizer, Inc. Ocular Inflammation Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.4 Novartis AG

2.4.1 Business Overview

2.4.2 Ocular Inflammation Treatment Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Novartis AG Ocular Inflammation Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.5 Valeant Pharmaceuticals International, Inc.

2.5.1 Business Overview

2.5.2 Ocular Inflammation Treatment Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Valeant Pharmaceuticals International, Inc. Ocular Inflammation Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.6 Alimera Sciences, Inc.

2.6.1 Business Overview

2.6.2 Ocular Inflammation Treatment Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Alimera Sciences, Inc. Ocular Inflammation Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.7 Akorn, Inc.

2.7.1 Business Overview

2.7.2 Ocular Inflammation Treatment Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Akorn, Inc. Ocular Inflammation Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.8 Abbvie, Inc.

2.8.1 Business Overview

2.8.2 Ocular Inflammation Treatment Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Abbvie, Inc. Ocular Inflammation Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.9 Eyegate Pharmaceuticals, Inc.

2.9.1 Business Overview

2.9.2 Ocular Inflammation Treatment Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Eyegate Pharmaceuticals, Inc. Ocular Inflammation Treatment Revenue, Gross Margin and Market Share (2016-2017)

2.10 pSivida Corporation

2.10.1 Business Overview

2.10.2 Ocular Inflammation Treatment Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 pSivida Corporation Ocular Inflammation Treatment Revenue, Gross Margin and Market Share (2016-2017)

3 Global Ocular Inflammation Treatment Market Competition, by Players

3.1 Global Ocular Inflammation Treatment Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Ocular Inflammation Treatment Players Market Share

3.2.2 Top 10 Ocular Inflammation Treatment Players Market Share

3.3 Market Competition Trend

4 Global Ocular Inflammation Treatment Market Size by Regions

4.1 Global Ocular Inflammation Treatment Revenue and Market Share by Regions

4.2 North America Ocular Inflammation Treatment Revenue and Growth Rate (2013-2018)

4.3 Europe Ocular Inflammation Treatment Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Ocular Inflammation Treatment Revenue and Growth Rate (2013-2018)

4.5 South America Ocular Inflammation Treatment Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Ocular Inflammation Treatment Revenue and Growth Rate (2013-2018)

5 North America Ocular Inflammation Treatment Revenue by Countries

5.1 North America Ocular Inflammation Treatment Revenue by Countries (2013-2018)

5.2 USA Ocular Inflammation Treatment Revenue and Growth Rate (2013-2018)

5.3 Canada Ocular Inflammation Treatment Revenue and Growth Rate (2013-2018)

5.4 Mexico Ocular Inflammation Treatment Revenue and Growth Rate (2013-2018)

6 Europe Ocular Inflammation Treatment Revenue by Countries

6.1 Europe Ocular Inflammation Treatment Revenue by Countries (2013-2018)

6.2 Germany Ocular Inflammation Treatment Revenue and Growth Rate (2013-2018)

6.3 UK Ocular Inflammation Treatment Revenue and Growth Rate (2013-2018)

6.4 France Ocular Inflammation Treatment Revenue and Growth Rate (2013-2018)

6.5 Russia Ocular Inflammation Treatment Revenue and Growth Rate (2013-2018)

6.6 Italy Ocular Inflammation Treatment Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Ocular Inflammation Treatment Revenue by Countries

7.1 Asia-Pacific Ocular Inflammation Treatment Revenue by Countries (2013-2018)

7.2 China Ocular Inflammation Treatment Revenue and Growth Rate (2013-2018)

7.3 Japan Ocular Inflammation Treatment Revenue and Growth Rate (2013-2018)

7.4 Korea Ocular Inflammation Treatment Revenue and Growth Rate (2013-2018)

7.5 India Ocular Inflammation Treatment Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Ocular Inflammation Treatment Revenue and Growth Rate (2013-2018)

8 South America Ocular Inflammation Treatment Revenue by Countries

8.1 South America Ocular Inflammation Treatment Revenue by Countries (2013-2018)

8.2 Brazil Ocular Inflammation Treatment Revenue and Growth Rate (2013-2018)

8.3 Argentina Ocular Inflammation Treatment Revenue and Growth Rate (2013-2018)

8.4 Colombia Ocular Inflammation Treatment Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Ocular Inflammation Treatment by Countries

9.1 Middle East and Africa Ocular Inflammation Treatment Revenue by Countries (2013-2018)

9.2 Saudi Arabia Ocular Inflammation Treatment Revenue and Growth Rate (2013-2018)

9.3 UAE Ocular Inflammation Treatment Revenue and Growth Rate (2013-2018)

9.4 Egypt Ocular Inflammation Treatment Revenue and Growth Rate (2013-2018)

9.5 Nigeria Ocular Inflammation Treatment Revenue and Growth Rate (2013-2018)

9.6 South Africa Ocular Inflammation Treatment Revenue and Growth Rate (2013-2018)

10 Global Ocular Inflammation Treatment Market Segment by Type

10.1 Global Ocular Inflammation Treatment Revenue and Market Share by Type (2013-2018)

10.2 Global Ocular Inflammation Treatment Market Forecast by Type (2018-2023)

10.3 Immunosuppressant Revenue Growth Rate (2013-2023)

10.4 Monoclonal Antibodies Revenue Growth Rate (2013-2023)

10.5 Corticosteroids Revenue Growth Rate (2013-2023)

10.6 Cycloplegic Agents Revenue Growth Rate (2013-2023)

10.7 Antibiotics Revenue Growth Rate (2013-2023)

10.8 Analgesics Revenue Growth Rate (2013-2023)

10.9 Antivirals Revenue Growth Rate (2013-2023)

10.10 Antifungal Revenue Growth Rate (2013-2023)

11 Global Ocular Inflammation Treatment Market Segment by Application

11.1 Global Ocular Inflammation Treatment Revenue Market Share by Application (2013-2018)

11.2 Ocular Inflammation Treatment Market Forecast by Application (2018-2023)

11.3 Retail Pharmacies Revenue Growth (2013-2018)

11.4 Hospital Pharmacies Revenue Growth (2013-2018)

11.5 Online Pharmacies Revenue Growth (2013-2018)

11.6 Drug Stores Revenue Growth (2013-2018)

12 Global Ocular Inflammation Treatment Market Size Forecast (2018-2023)

12.1 Global Ocular Inflammation Treatment Market Size Forecast (2018-2023)

12.2 Global Ocular Inflammation Treatment Market Forecast by Regions (2018-2023)

12.3 North America Ocular Inflammation Treatment Revenue Market Forecast (2018-2023)

12.4 Europe Ocular Inflammation Treatment Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Ocular Inflammation Treatment Revenue Market Forecast (2018-2023)

12.6 South America Ocular Inflammation Treatment Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Ocular Inflammation Treatment Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Ocular Inflammation Treatment Picture

Table Product Specifications of Ocular Inflammation Treatment

Table Global Ocular Inflammation Treatment and Revenue (Million U

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery